	Kısa Vadeli Yükümlülükler		Tarih
AbbVie	USD 43.29B	3.9B	2025-12
Acadia Pharmaceuticals	USD 356.58M	26.56M	2025-09
Agios Pharmaceuticals	USD 82.21M	7.45M	2025-12
Alnylam Pharmaceuticals	USD 1.47B	89.13M	2025-12
Amgen	USD 25.49B	3.7B	2025-12
Arrowhead Research	USD 347.42M	151.94M	2025-12
Biogen	USD 3.35B	59.4M	2025-12
BioMarin Pharmaceutical	USD 798.44M	114.19M	2025-09
Bristol-Myers Squibb	USD 28.14B	608M	2025-09
Gilead Sciences	USD 11.81B	485M	2025-12
Incyte	USD 1.52B	176.44M	2025-12
Insmed	USD 468.87M	51.66M	2025-12
Ionis Pharmaceuticals	USD 903.46M	6.22M	2025-09
J&J	USD 54.13B	3.26B	2025-12
Merck	USD 28.63B	2.59B	2025-09
Moderna	USD 1.99B	306M	2025-12
Neurocrine Biosciences	USD 743.4M	105.4M	2025-12
Novartis	USD 32B	286M	2025-09
Pfizer	USD 36.6B	1.13B	2025-09
PTC Therapeutics	USD 968.43M	102.18M	2025-12
Puma Biotechnology	USD 82.73M	3.63M	2025-09
Regeneron Pharmaceuticals	USD 4.37B	56.7M	2025-12
Roche Holding	CHF 28B	421M	2025-12
Sangamo BioSciences	USD 47.66M	1.9M	2025-06
Sanofi	EUR 28.35B	3.76B	2025-12
Sarepta Therapeutics	USD 921.42M	1.48M	2025-09
Ultragenyx Pharmaceutical	USD 340.02M	46.78M	2025-09
United Therapeutics	USD 546.3M	19.2M	2025-09
Vertex Pharmaceuticals	USD 3.86B	614.1M	2025-12

Vertex Pharmaceuticals Kısa Vadeli Yükümlülükler - Akım değerleri, tarihsel veriler, tahminler, istatistikler, grafikler ve ekonomik takvim - Feb 2026.